Stocktoria
CervoMed Inc. CRVO
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2016-11-09
CervoMed Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
CervoMed Inc. trades at about 0× earnings — below its 10-year norm (10-year range 0×–0×, median 0×).
0×
0×
Shaded band = 10-year range (0×–0×); dot = today's 0×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -706.2% | -187.2% | -109.3% | — | — | — | — | — | — | — |
| Net margin | -673.1% | -167.3% | -30.4% | — | — | — | — | — | — | — |
| Return on assets | -117.9% | -37.8% | -21.8% | -139.6% | -63.7% | -51.2% | -48.9% | -100.9% | -5.2% | -103.2% |
| Return on equity | -148.0% | -41.6% | -29.4% | 17.4% | -69.0% | -57.2% | -58.6% | -117.7% | -6.4% | -196.4% |
| Current ratio | 4.91 | 11.11 | — | — | 12.92 | 7.71 | 8.51 | 11.09 | 3.59 | 0.36 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.